SERCA2 dysfunction stimulates inflammation and causes pulmonary vascular remodeling by downregulating PPARγ/PGC1α/Nrf2Yixiang Qiu, Xiaoyong Tong, Yufei Xie et al.|European Journal of Pharmacology|2025Cited by 1